Combined the three independent cohorts, we ultimately narrowed down a group of four proteins, COL12A1, THBS2, S100A8, and S100A9, significantly increased both in plasma and tissues of CRC patients in our study and the CPTAC study (Fig. 2B). Here, THBS2 is linked to colorectal carcinoma.